Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.
The technology of MIT alumni-founded Hosta AI creates detailed property assessments from photos.
MIT spinout Verta, founded by Manasi Vartak, SM ’14, PhD ’18, offers tools to help companies introduce, monitor, and manage machine-learning models safely and at scale.
MassRobotics, a nonprofit founded by several MIT alumni, is advancing an industry that will play an increasingly important role in our lives.
How does Libra work? How you will be able to use it once it goes live? And what is Calibra doing to address issues around privacy and security?